Wednesday, 21 November 2018

FDA approves new blood cancer treatment from Pfizer

The U.S. Food and Drug Administration on Wednesday approved Pfizer Inc's drug to treat a form of blood cancer in newly diagnosed patients as a combination therapy.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)